MDMA (ecstasy) modulates locomotor and prefrontal cortex sensory evoked activity

Brain Research

Volumn 1302, Issue , 2009, Pages 175-182

  Atkins, Kristal ^a   Burks, Tilithia ^a   Swann, Alan C ^a   Dafny, Nachum ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Behavior; MDMA; Rat; Sensory evoked potential

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; EVOKED AUDITORY RESPONSE; EVOKED SOMATOSENSORY RESPONSE; LOCOMOTION; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SENSORY STIMULATION;

ANIMALS; AUDITORY PERCEPTION; BEHAVIOR, ANIMAL; DRUG ADMINISTRATION SCHEDULE; ELECTRODES, IMPLANTED; EVOKED POTENTIALS; EVOKED POTENTIALS, AUDITORY; HALLUCINOGENS; MALE; MOTOR ACTIVITY; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PERCEPTION; PREFRONTAL CORTEX; RATS; RATS, INBRED WKY; SENSATION; SENSATION DISORDERS;

RATTUS;

EID: 71849114311     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.09.048     Document Type: Article

References (60)

1. Baumann M.H., Clark R.D., and Rothman R.B. Locomotor stimulation produced 3,4-methylenedioxymethamphetamine (MDMA) is correlated with dialysate levels of serotonin and dopamine in rat brain. Pharmacol. Biochem. Behav. 90 (2008) 208-217
2. Biezonski D.K., Courtemanche A.B., Hong S.B., Piper B.J., and Meyer J.S. Repeated adolescent MDMA ("Ecstacy") exposure in rats increases behavioral and neuroendocrine responses to a 5-HT2A/2C agonist. Brain Res. 1252 (2009) 87-93
3. Burgess C., O'Donohoe A., and Gill M. Agony and ecstasy: a review of MDMA effects and toxicity. Eur. Psychiatry 15 (2000) 287-294
4. Capela J.P., Carmo H., Remião F., Bastos M.L., Meisel A., and Carvalho F. Molecular and cellular mechanisms to ecstasy-induced neurotoxicity: an overview. Mol. Neurobiol. 39 (2009) 210-271
5. Cavada C., and Goldman-Rakic P.S. Posterior parietal cortex in rhesus monkey: II. Evidence for segregated corticocortical networks liking sensory and limbic areas with the frontal lobe. J. Comp. Neurol. 287 (1989) 422-445
6. Dafny N. Neurophysiological evidence for tolerance and dependence on opiates: simultaneous multiunit recordings from septum, thalamus, and caudate nucleus. J. Neurosci. Res. 5 (1980) 339-349
7. Dafny N. The hypothalamus exhibits electrophysiologic evidence for morphine tolerance and dependence. Exp. Neurol. 77 (1982) 66-77
8. Dafny N., Phillips M.I., Taylor N.A., and Gilman S. Dose effects of cortisol on single unit activity in hypothalamus, reticular formation, and hippocampus of freely behaving rats correlated with plasma steroid levels. Brain Res. 59 (1973) 257-272
9. Dafny N., Marchand J., McClung R., Salamy J., Sands S., Wachtendorf H., and Burks T.F. Effects of morphine on sensory evoked responses recorded from central gray, reticular formation, thalamus, hypothalamus, limbic system, basal ganglia, dorsal raphe, locus ceruleus, and pineal body. J. Neurosci. Res. 5 (1993) 399-412
10. Dafters R.I. Hyperthermia following MDMA administration in rats: effects of ambient temperature, water consumption, and chronic dosing. Physiol. Behav. 58 (1995) 877-882
11. De Sola S., Tarancón T., Peña-Casanova J., Espadaler J.M., Langohr K., Poudevida S., Farré M., Verdejo-Garcia A., and de la Torre R. Auditory event-related potentials (P3) and cognitive performance in recreational ecstasy polydrug users: evidence from a 12-month longitudinal study. Psychopharmacology 200 (2008) 425-437
12. Drouin C., and Waterhouse B.D. Cocaine-induced vs. behavior-related alterations of spontaneous and evoked discharge of somatosensory cortical neurons. Eur. J. Neurosci. 19 (2004) 1016-1026
13. Everitt B.K., and Robbins T.W. Second-order schedules of drug reinforcement in rats and monkeys: measurement of reinforcing efficacy and drug-seeking behavior. Psychopharmnacology Berl. 153 (2000) 17-30
14. Everitt B.J., Parkinson J.A., Olmstead M.C., Arroyo M., Robledo P., and Robbins T.W. Associative processes in addiction and reward. The role of amygdale-ventral striatal subsystems. Ann. N.Y. Acad. Sci. 877 (1999) 412-438
15. Fone K.C., Beckett S.R., Topham I.A., Swettenham J., Ball M., and Maddocks L. Long-term changes in social interaction and reward following repeated MDMA administration to adolescent rats without accompanying serotonergic neurotoxicity. Psychopharmacology Berl. 159 (2002) 437-444
16. Feduccia A.A., and Duvauchelle C.L. Auditory stimuli enhances MDMA-conditioned reward and MDMA-induced nucleus accumbens dopamine, serotonin, and locomotor responses. Brain Res. Bull. 77 (2008) 189-196
17. Funahashi S., Bruce G.I., and Goldman-Rakic P.S. Mnemonic coding of visual space in the monkey's dorsolateral prefrontal cortex. J. Neurophysiol. 61 (1989) 331-349
18. Gaytan O., Al-Rahim S., Swann A., and Dafny N. Sensitization to locomotor effects of methylphenidate in the rat. Life Sci. 61 (1997) PL101-PL107
19. Gaytan O., Swann A., and Dafny N. Diurnal differences in rat's motor response to amphetamine. Eur. J. Pharmacol. 345 (1998) 119-128
20. Gaytan O., Lewis C., Swann A., and Dafny N. Diurnal differences in amphetamine sensitization. Eur. J. Pharmacol. 374 (1999) 1-9
21. Gaytan O., Yang P., Swann A., and Dafny N. Diurnal differences in sensitization to methylphenidate. Brain Res. 864 (2000) 24-39
22. Gold L.H., and Koob G.F. MDMA produces stimulant-like conditioned locomotor activity. Psychopharmacology 99 (1989) 352-356
23. Goldman-Rakic P.S. Circuitry of the primate prefrontal cortex and the regulation of behavior by representational memory. In: Plum F. (Ed). Handbook of Physiology. The Nervous System. Higher Functions of the Brain (1987), American Physiological Society, Bethesda, M.D. 373-417 Section 1, Volume 5 Part 1
24. Goldman-Rakic P.S., and Nauta W.J.H. An intricately patterned prefronto-caudate projection in the rhesus monkey. J. Comp. Neurol. 171 (1977) 369-386
25. Green A.R., Cross A.J., and Cross G.M. Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy"). Psychopharmacology 119 (1995) 247-260
26. Gudelsky G.A., and Nash J.F. Carrier-mediated release of serotonin by 3,4- methylenedioxymethamphetamine: implications for serotonin-dopamine interactions. J. Neurochem. 66 (1996) 243-249
27. Gudelsky G.A., and Yamamoto B.K. Actions of 3,4-methylenedioxymethamphetamine (MDMA) on cerebral dopaminergic, serotonergic and cholinergic neurons. Pharmacol. Biochem. Behav. 90 (2008) 198-207
28. Ho Y.J., Pawlak C.R., Guo L., and Schwarting R.K. Acute and long-term consequences of single MDMA administration in relation to individual anxiety levels in the rat. Behav. Brain Res. 149 (2004) 135-144
29. Itzhak Y., Ali S.F., Achat C.N., and Anderson K.L. Relevance of MDMA ("ecstasy")-induced neurotoxicity to long-lasting psychomotor stimulation in mice. Psychopharmacology Berl. 166 (2003) 241-248
30. Konig J.F.R., and Klippel R.A. The rat brain. A stereotaxic atlas of the forebrain and lower parts of the brain stem (1970), R.E. Krieger Publishing Co., Inc., Melbourne
31. Liechti M.E., Baumann C., Gamma A., and Vollenweider F.X. Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") are attenuated by the serotonin uptake inhibitor citalopram. Neuropsychopharmacology 22 (2000) 513-521
32. Marona-Lewicka D., Rhee G.S., Sprague J.E., and Nichols D.E. Reinforcing effects of certain serotonin-releasing amphetamine derivatives. Pharmacol. Biochem. Behav. 53 (1996) 99-105
33. Marston H.M., Reid M.E., Lawrence J.A., Olverman H.J., and Butcher S.P. Behavioural analysis of the acute and chronic effects of MDMA treatment in the rat. Psychopharmacology 144 (1999) 67-76
34. Martin P.R., Lavinger D.M., and Breese G.R. Alcohol and other abused substances. In: Munson P.L. (Ed). Prin. of Pharmacol. (1995) 441-442
35. Mayerhofer A., Kovar K.A., and Schmidt W.J. Changes in serotonin, dopamine and noradrenaline levels in striatum and nucleus accumbens after repeated administration of the abused drug MDMA in rats. Neurosci. Lett. 308 (2001) 99-102
36. McNamara M.G., Kelly J.P., and Leonard B.E. Some behavioral and neurochemical aspects of subacute (+/-)3,4-methylenedioxymethamphetamine administration in rats. Pharmacol. Biochem. Behav. 52 (1995) 479-484
37. Modi G.M., Young P.B., Swann A.C., and Dafny N. Chronic exposure to MDMA (ecstasy) elicits behavioral sensitization in rats fails to induce cross sensitization to other psychostimulants. Behav. Brain Function 2 (2006) 1-11
38. Montoya A.G., Sorrentino R., Lukas S.E., and Price B.H. Long-term neuropsychiatric consequences of "ecstasy" (MDMA): a review. Harvard Rev. Psychiatry 10 (2002) 212-220
39. NIDA InfoFacts: MDMA (Ecstasy) 2004 at www.nida.nih.gov./Infofacts/ecstasy.html.
40. Pálenicek T., Hlinák Z., Bubeníková-Valesová V., Votava M., and Horácek J. An analysis of a spontaneous behavior following acute MDMA treatment in male and female rats. Neuro. Endocrinol. Lett. 28 (2007) 781-788
41. Pan H.S., and Wang R.Y. The action of (+/-)-MDMA on medial prefrontal cortical neurons is mediated through the serotonergic system. Brain Res. 543 (1991) 56-60
42. Parrott A.C. MDMA (3,4- methylenedioxymethamphetamine) or "ecstasy": The neuropsychobiological implications of taking it at dances and raves. Neuropsychology 50 (2004) 329-335
43. Ramos M., Goni-Allo B., and Aguirre N. Ibotenic acid lesions of the medial prefrontal cortex block the development and expression of 3,4-methylenedioxymethamphetamine-induced behavioral sensitization in rats. Behav. Brain Res. 160 (2005) 304-311
44. Ricuarte G.A., and McCann U.D. Assessing long-term effects of MDMA (ecstasy). Lancet 358 (2001) 1831-1832
45. Ricuarte G.A., Yuan J., and McCann U.D. (+)3,4-Methylenedioxymethamphetamine ("ecstasy")-induced serotonin neurotoxicity: studies in animals. Neuropsychobiology 42 (2000) 5-10
46. Rogers J. Cognitive performance amongst recreational users of "ecstasy.". Psychopharmacology 151 (2000) 19-24
47. Sessler F.M., Liu W., Kirifides M.L., Mouradian R.D., Lin R.C., and Waterhouse B.D. Noradrenergic enhancement of GABA-induced input resistance changes in layer V regular spiking pyramidal neurons of rat somatosensory cortex. Brain Res. 675 (1995) 171-182
48. Shankaran M., Yamamoto B.K., and Gudlesky G.A. Involvement of the serotonin transporter in the formation of hydroxyl radicals induced by 3,4- methylenedioxymethamphetamine. Eur. J. Pharmacol. 385 (1999) 103-110
49. Spanos L.J., and Yamamoto B.K. Acute and subchronic effects of methylenedioxymethamphetamine [+/-)-MDMA] on locomotion and serotonin syndrome behavior in the rat. Pharmacol. Biochem. Behav. 32 (1989) 835-840
50. Sprague J.E., Preston A.S., Leifheit M., and Woodside B. Hippocampal serotonergic damage induced by MDMA (ecstasy): effects on spatial learning. Physiol. Behav. 79 (2003) 281-287
51. Steele T.D., McCann U.D., and Ricaurte G.A. 3,4-Methlyenedioxymethamphetamine (MDMA, "ecstasy"): pharmacology and toxicology in animals and humans. Addiction 89 (1994) 539-551
52. Wang X., Baumann M.H., Xu H., and Rothman R.B. 3,4-methyldioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein. Synapse 53 (2004) 240-248
53. Waterhouse B.D., Moises H.C., and Woodward D.J. Interaction of serotonin with somatosensory cortical neuronal responses to afferent synaptic inputs and putative neurotransmitters. Brain Res. Bull. 17 (1986) 507-518
54. Winsauer P.J., Quinton M.S., Porter J.R., Corll C.B., Moerschbaecher J.M., Delatte M.S., Leonard S.T., and Stroble S.B. Effects of MDMA administration on scopolamine-induced disruptions of learning and performance in rats. Pharmacol. Biochem. Behav. 79 (2004) 459-472
55. Wood J.N., and Grafman J. Human prefrontal cortex: procession and representational perspectives. Nat. Rev. Neurosci. 4 (2003) 139-147
56. Yang P., Swann A., and Dafny N. NMDA receptor antagonist disrupts acute and chronic effects of methylphenidate. Physiol. Behav. 71 (2000) 133-145
57. Yang P., Singhal N., Modi G., Swann A., and Dafny N. Effects of lithium chloride on induction and expression of methylphenidate sensitization. Eur. J. Pharmacol. 426 (2001) 65-72
58. Yang P.B., Behrang A., Swann A.C., and Dafny N. Strain differences in the behavioral responses of male rats to chronically administered methylphenidate. Brain Res. 971 (2003) 139-152
59. Yang P.B., Swann A.C., and Dafny N. Sensory-evoked potentials recordings from the ventral tegmental area, nucleus accumonse, prefrontal cortex and caudate nucleus and locomotor activity are modulated in dose-response characteristics by methylphenidate. Brain Res. 1073 (2006) 164-174
60. Yang P.B., Swann A.C., and Dafny N. Methylphenidate treated at the test cage-dose dependent sensitization or tolerance depend on the behavioral assay used. Crit. Rev. Neurosci. 19 (2007) 59-77